| Autor: |
Giannitsioti, Efthymia, Louka, Christina, Mamali, Vasiliki, Kousouli, Elisavet, Velentza, Lemonia, Papadouli, Vaia, Loizos, Georgios, Mavroudis, Panagiotis, Kranidiotis, Georgios, Rekleiti, Nektaria, Stamati, Alexandra, Speggos, Ioannis, Daniil, Ioannis, Kouvatsos, Panagiotis, Sidiropoulou, Chrysanthi, Linardaki, Garifallia, Gerakari, Styliani, Chrysos, Georgios, Themeli-Digalaki, Katina, Zarkotou, Olympia |
| Předmět: |
|
| Zdroj: |
Microorganisms; Jul2022, Vol. 10 Issue 7, pN.PAG-N.PAG, 12p |
| Abstrakt: |
Background: Bloodstream infections (BSI) caused by highly resistant pathogens in non-ICU COVID-19 departments pose important challenges. Methods: We performed a comparative analysis of incidence and microbial epidemiology of BSI in COVID-19 vs. non-COVID-19, non-ICU departments between 1 September 2020-31 October 2021. Risk factors for BSI and its impact on outcome were evaluated by a case-control study which included COVID-19 patients with/without BSI. Results: Forty out of 1985 COVID-19 patients developed BSI. The mean monthly incidence/100 admissions was 2.015 in COVID-19 and 1.742 in non-COVID-19 departments. Enterococcus and Candida isolates predominated in the COVID-19 group (p < 0.001 and p = 0.018, respectively). All Acinetobacter baumannii isolates were carbapenem-resistant (CR). In the COVID-19 group, 33.3% of Klebsiella pneumoniae was CR, 50% of Escherichia coli produced ESBL and 19% of Enterococcus spp. were VRE vs. 74.5%, 26.1% and 8.8% in the non-COVID-19 group, respectively. BSI was associated with prior hospitalization (p = 0.003), >2 comorbidities (p < 0.001), central venous catheter (p = 0.015), severe SARS-CoV-2 pneumonia and lack of COVID-19 vaccination (p < 0.001). In the multivariate regression model also including age and multiple comorbidities, only BSI was significantly associated with adverse in-hospital outcome [OR (CI95%): 21.47 (3.86–119.21), p < 0.001]. Conclusions: BSI complicates unvaccinated patients with severe SARS-CoV-2 pneumonia and increases mortality. BSI pathogens and resistance profiles differ among COVID-19/non-COVID-19 departments, suggesting various routes of pathogen acquisition. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
